Page 1919 - Saunders Comprehensive Review For NCLEX-RN
P. 1919

Content Area: Pharmacology: Renal and Urinary Medications: Urinary tract
               antiseptics
                  Health Problem: Adult Health: Renal and Urinary: Inflammation/Infections
                  Priority Concepts: Elimination; Safety
                  Reference: Lewis et al. (2017), p. 1036.

                   674. Answer: 1


                  Rationale: Epoetin alfa is synthetic erythropoietin, which the kidneys produce to
               stimulate red blood cell production in the bone marrow. It is used to treat anemia
               associated with chronic kidney disease. The normal hematocrit level is 42% to 52%
               (0.42 to 0.52) for males and 37% to 47% (0.37 to 0.47) for females. Therapeutic effect is
               seen when the hematocrit reaches between 30% and 33% (0.30 and 0.33). The normal
                                                                          9
                                                         3
               platelet count is 150,000 to 400,000 mm  (150 to 400 × 10 /L). The normal blood urea
               nitrogen level is 10 to 20 mg/dL (3.6 to 7.1 mmol/L). The normal white blood cell
                                            3
                                                          9
               count is 5000 to 10,000 mm  (5 to 10 × 10 /L). Platelet production, white blood cell
               production, and blood urea nitrogen do not respond to erythropoietin.
                  Test-Taking Strategy: Focus on the subject, a therapeutic effect. Relate the name
               of the medication, epoetin alfa, to the potential action or effect of erythropoietin. The
               only laboratory test that would reflect the effect of this medication is a hematocrit of
               33% (0.33), found in the correct option.
                  Level of Cognitive Ability: Evaluating
                  Client Needs: Physiological Integrity
                  Integrated Process: Nursing Process—Evaluation
                  Content Area: Pharmacology: Hematological Medications: Hematopoietic agents
                  Health Problem: Adult Health: Renal and Urinary: Chronic kidney disease
                  Priority Concepts: Clinical Judgment; Evidence
                  Reference: Skidmore-Roth (2017), p. 441.


                   675. Answer: 1


                  Rationale: Ciprofloxacin is prescribed for treatment of mild, moderate, severe,
               and complicated infections of the urinary tract, lower respiratory tract, and skin and
               skin structure. A single dose is administered slowly over 60 minutes to minimize
               discomfort and vein irritation. Ciprofloxacin is not light-sensitive, may be infused
               through a peripheral IV access, and is not given by IV push method.
                  Test-Taking Strategy: Focus on the subject, the appropriate way to administer an
               IV medication ciprofloxacin. Recall that this medication has adverse effects, so IV
               push would not be the recommended method of administration. Eliminate option 3
               because of the closed-ended word, “only.” Next, it is necessary that the presence of
               light does not affect the integrity of this medication.
                  Level of Cognitive Ability: Applying
                  Client Needs: Physiological Integrity
                  Integrated Process: Nursing Process—Implementation
                  Content Area: Pharmacology: Renal and Urinary Medications: Urinary tract
               antiseptics
                  Health Problem: Adult Health: Renal and Urinary: Inflammation/Infections



                                                         1919
   1914   1915   1916   1917   1918   1919   1920   1921   1922   1923   1924